| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |